Pfizer Inc. (PFE) News Headlines

▮ More

Date

Headline

10/21/2021 6:47:51 AM Pfizer And BioNTech Say Phase 3 Trial Data Shows High Efficacy Of Booster Dose Of Their COVID-19 Vaccine

10/19/2021 8:33:19 AM Will FDA Allow 'mix And Match' Of Covid Booster Shots?

10/15/2021 8:02:09 AM Pfizer's Abrocitinib Receives Positive CHMP Opinion For Atopic Dermatitis Treatment

10/15/2021 7:53:51 AM Pfizer's Abrocitinib Gets Positive CHMP Opinion For Treatment Of Adults With Moderate To Severe Atopic Dermatitis

10/14/2021 5:09:04 PM FDA Advisory Panel Recommends Moderna's Covid-19 Booster Dose

10/7/2021 10:26:52 AM Pfizer Seeks Emergency Nod In U.S. For COVID-19 Vaccine In Children 5 - 11

10/7/2021 9:52:58 AM Pfizer Seeks Emergency Nod In U.S. For COVID-19 Vaccine For Children 5 To Below 12

10/6/2021 7:23:29 AM Voyager Therapeutics Announces Licensing Agreement With Pfizer

10/4/2021 11:35:59 PM EMA Committee Recommends Pfizer, Moderna COVID-19 Booster Doses

9/30/2021 7:24:03 AM Japan's MHLW OKs Pfizer's CIBINQO To Treat Moderate To Severe Atopic Dermatitis

9/30/2021 6:48:55 AM Pfizer Says Japan's MHLW Approves CIBINQO For Adults And Adolescents With Moderate To Severe Atopic Dermatitis

9/29/2021 7:26:22 AM Pfizer: Trial Data From Coadministration Of Prevnar 20 With Seasonal Flu Vaccine Positive

9/29/2021 6:49:57 AM -Pfizer Reports Positive Top-line Results From Phase 3 Study Exploring Coadministration Of Prevnar 20

9/28/2021 10:27:13 PM FDA Expands Lilly's Erbitux Label With Braftovi For Treatment Of Metastatic Colorectal Cancer

9/28/2021 7:21:30 AM Pfizer, BioNTech Submit Positive Data From COVID-19 Vaccine Trial In 5 To <12 Years To FDA

9/28/2021 7:00:15 AM ViiV Healthcare Announces FDA's Priority Review Designation For Cabotegravir

9/28/2021 6:50:18 AM ViiV Enters Collaboration And License Agreement With Shionogi To Develop HIV Integrase Inhibitor

9/28/2021 6:49:57 AM Pfizer, BioNTech Submit Initial Data To FDA From Phase 2/3 Trial Trial Of COVID-19 Vaccine In Children 5 To <12 Years

9/28/2021 6:45:42 AM ViiV Healthcare: FDA Grants Priority Review To Cabotegravir NDA For Prevention Of HIV

9/28/2021 1:06:23 AM Valneva, Pfizer Announce Further Positive Phase 2 Results For Lyme Disease Vaccine Candidate VLA15